GORE TAG Thoracic Branch Endoprosthesis TAC123420ARecalls & reported problems
W. L. Gore & Associates, Inc. · TAG TBE AORTIC COMPONENT TAG TBE AC 12MMX34MMX20CM · Class 3 · Implant
All models of GORE TAG Thoracic Branch Endoprosthesis (30)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132654208), received between Apr 30, 2026 and Apr 30, 2026 — classified as 1 malfunction.
The most frequently reported specific device problem is “Activation Failure” (1 report).
1 other recall cover devices cleared under the same FDA submission (P210032); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Activation Failure1
- Material Frayed1
- Off-Label Use1
Patient problems
- Unspecified Vascular Problem1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 30, 2026Material Frayed; Off-Label Use; Activation Failure
THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2026, A PATIENT WAS TREATED FOR A ZONE 0 CHRONIC DISSECTION USING A PHYSICIAN MODIFIED GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS (TBE). THE DEVICE WAS MODIFIED TO CREATE FENESTRATIONS FOR THE LEFT COMMON CAROTID AND LEFT SUBCLAVIAN. IN THE PROCESS OF PERFORMING THIS MODIFICATION, THE PRIMARY SLEEVE WAS OPENED FOR A 3 CM SEGMENT ON THE SIDE OF THE DEVICE ADJACENT TO THE PORTAL. AFTER ADVANCING THE DEVICE TO THE TRANSVERSE THORACIC AORTA, THEY REALIZED THE DEVICE HAD WIRE WRAP WITH THE INNOMINATE WIRE. THEY ROTATED 2-3 TIMES COUNTER-CLOCKWISE, REALIZED THAT WAS THE WRONG DIRECTION, AND ROTATED THE OTHER WAY. AFTER 10 MINUTES, THE TBE WAS ABLE TO BE ADVANCED THROUGH THE SHEATH. ONCE IN POSITION, THEY PULLED THE DEPLOYMENT LINE. HOWEVER, THE DEVICE DID NOT DEPLOY AND REMAINED CONSTRAINED. THE PHYSICIAN TRIED TO SNARE THE PARTIALLY OPEN END OF THE TBE DEVICE, AND PULL IT BACK INTO THE DSF, BUT AFTER 45 MINUTES THEY ABANDONED THIS. THEY THEN REMOVED THE DSF AND TBE TOGETHER. THE RIGHT EXTERNAL AND COMMON ILIACS WERE DAMAGED BY THE GRAFT AND REPAIRED USING A PATCH ENDARTERECTOMY. THE PROCEDURE WAS ABORTED, AND NO DEVICES WERE IMPLANTED. THE PA
Patient problems: Unspecified Vascular Problem
MAUDE report 25049241 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P210032. One submission often covers many models, so check the product and lot details in each record.
- Z-2672-2026 · May 19, 2026 · Open, ClassifiedGORE TAG Thoracic Branch Endoprosthesis Side Branch Component Catalog Numbers (by Region) United States (includes Puerto Rico) and Canada: TSB080806A, TSB081006A, TSB081206A, TSB08
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page